N-Benzyl-2-chloro-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide

N-Benzyl-2-chloro-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide Suppliers list

Company Name:	Zhuhai Aobokai Biomedical Technology Co., Ltd.
Tel:	400-0628126 18736790110;
Email:	sales-team@aobchem.com.cn
Products Intro:	Product Name:N-benzyl-2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide CAS:3032560-37-2 Purity:95%+ Package:1g;5kg Remarks:72702

N-Benzyl-2-chloro-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide Basic information

Product Name:	N-Benzyl-2-chloro-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide
Synonyms:	N-Benzyl-2-chloro-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide;Benzamide, 2-chloro-N-(phenylmethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS:	3032560-37-2
MF:	C20H23BClNO3
MW:	371.67
EINECS:
Product Categories:
Mol File:	3032560-37-2.mol

N-Benzyl-2-chloro-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide Chemical Properties

Boiling point	512.1±50.0 °C(predicted)
density	1.19±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)
pka	14.28±0.46(predicted)

Safety Information

MSDS Information

N-Benzyl-2-chloro-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide Usage And Synthesis

N-Benzyl-2-chloro-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide Preparation Products And Raw materials

Tag:N-Benzyl-2-chloro-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide(3032560-37-2) Related Product Information

N-cyclopropyl-2,6-difluoro-4-methoxybenzamide N-cyclopropyl-3-fluoro-5-(trifluoromethyl)benzamide N-cyclopropyl-6-methoxy-2-methylnicotinamide N-cyclohexyl-3-fluoro-5-(trifluoromethyl)benzamide N-cyclohexyl-2,3,4-trimethoxybenzamide N-cyclohexyl-6-methoxy-2-methylnicotinamide N-Cyclopropyl-4-fluoro-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide N-cyclohexyl-2,6-difluoro-4-methoxybenzamide N-cyclopropyl-2,3,4-trimethoxybenzamide N-benzyl-2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

Login